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Abstract
Background: The presence of cervical lymph node metastasis is an important prognostic factor for patients with
head and neck squamous cell carcinomas (HNSCC). Accurate assessment of lymph node metastasis in these
patients is essential for appropriate prognostic and management purposes. Here, we evaluated the effectiveness of
the maximum standardized uptake value (SUVmax) on positron emission tomography (PET) in assessing lymph node
metastasis in HNSCC prior to surgery.
Methods: A retrospective review of 74 patients with HNSCC who underwent PET/CT prior to neck dissection were
examined. Pre-operative PET/CT scans were reviewed by two experienced nuclear medicine physicians and SUVmax
of the largest node in each nodal basin documented. These were compared with the histology results of the neck
dissection.
Results: A total of 359 nodal basins including 86 basins with metastatic nodes were evaluated. A nodal SUVmax ≥3.
16 yielded a sensitivity of 74.4 % and specificity of 84.9 % in detecting metastatic nodes. The nodal SUVmax/Liver
SUVmax ratio was found on receiver operating characteristic (ROC) to be effective in detecting metastatic nodes
with an area under ROC curve of 0.90. A nodal SUVmax/Liver SUVmax ratio ≥0.90 yielded a sensitivity of 74.1 % and
specificity of 93.4 %. By comparison, visual inspection yielded sensitivities of 66.3 and 61.6 % in observers 1 and 2
respectively. The corresponding specificities were 77.7 and 86.5 %.
Conclusions: Nodal SUVmax and nodal SUVmax/liver SUVmax are both useful in the pre-operative detection of
metastatic nodes with the latter being superior to visual inspection. The ratio is likely to be more useful as it
corrects for inter-scanner variability.
Keywords: Lymphadenopathy, Metastasis, Positron emission tomography (PET), Standardized uptake value,
Squamous cell carcinoma
Background
Accurate nodal staging of the neck is essential in guiding
management and predicting prognosis for patients with
head and neck squamous cell carcinoma (HNSCC). A
single nodal metastasis reduces a patient’s survival rate
by 50 %–this is further halved with bilateral lymphadenop-
athy [1–3]. The use of 18F-fluorodeoxyglucose positron
emission tomography (18 F-FDG PET) in the workup of
HNSCC has allowed non-invasive, quantitative assessment
of a tissue by analysing the 3-dimensional distribution of
radioactivity based on the annihilation photons that are
emitted by labelled tracer [4]. PET scans are superior to
computed tomography (CT) and magnetic resonance
imaging (MRI) because metabolic changes resulting from
malignancies precede structural changes [5]. However,
while providing metabolic information about tissues, PET
scans offer poor visualization of anatomic structures,
thereby limiting their use. This shortcoming has been
overcome by integrated 18F-FDG PET/CT scanners and
has improved the nodal staging of the neck [6, 7].
At present, there have been only two studies that have
examined the relationship between the maximum
standardized uptake value (SUVmax) of a node and the
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presence of nodal metastasis [8, 9]. Both studies used
nodal SUVmax in conjunction with nodal size measured
from the CT images to predict nodal metastasis. There
have been no studies using nodal SUVmax alone or using
a ratio nodal SUVmax and background tissue SUVmax to
negate variables that could cause different SUVmax read-
ings between patients and between institutions.
The aims of this study were to define a nodal SUVmax
cut-off with the greatest sensitivity and specificity for the
detection of nodal metastasis, as well as to determine if
a ratio between nodal SUVmax and each of aortic blood
pool SUVmax, liver SUVmax and primary tumour SUVmax




This retrospective single tertiary centre study identified
74 patients from January 2011 to December 2014 with
newly diagnosed HNSCC who had undergone elective
neck dissection with curative intent at the Department
of Otolaryngology and Head & Neck Surgery, Monash
Health, Melbourne.
The exclusion criteria included the following: patients
who had previous chemotherapy or radiotherapy for any
malignancy; patients who did not undergo pre-operative
18 F-FDG PET/CT or had 18 F-FDG PET/CT scans
performed external to our institution; patients whose
neck dissection specimens were not clearly divided into
the individual levels; and patients who did not have a
HNSCC, were excluded. The study protocol was
approved by the ethics committee at Monash Health.
PET/CT imaging and SUV measurements
18 F-FDG PET/CT scans were obtained with an ad-
vanced integrated PET/CT scanner (Siemens Biograph™
TruePoint™). All patients were fasted for at least six
hours prior to the PET/CT examination. A standard
dose of 300 MBq 18 F-FDG tracer was used for all
patients. In the period between injection of 18 F-FDG
tracer and image acquisition, the patient was instructed
to remain seated or recumbent and silent in order to
minimize muscular 18 F-FDG uptake. Patients were kept
warm 30–60 min prior to tracer injection and through-
out the uptake period in order to minimize 18 F-FDG
accumulation in brown fat. Blood glucose was measured
for all diabetic patients to ensure that it was within ac-
ceptable limits. Patients with blood glucose >10 mmol/L
were rescheduled. Image acquisition was performed 53
to 124 min after tracer injection. Dual time point
imaging was not used in this study.
A standard scan for suspected HNSCC at our institu-
tion covered vertex to upper thighs. The CT images
were acquired without contrast and comprised of a
topogram and the helical CT scan. The reconstruction
parameters used for a standard scan were 168matrix,
True D reconstruction, FWHM 5.0, 3 iterations, 21
subsets and 1.0 zoom.
After the acquisition, SUVmax was assessed on the
Siemens syngo MultiModality WorkPlace (MMWP)
system by a single nuclear medicine physician. SUVmax
was determined by manually placing a cylindrical region
of interest (ROI) over the largest lymph node in each
nodal basin of interest, as well as the primary tumour
site, the descending aorta and liver. This was done on
trans-axial images by an experienced nuclear medicine
physician. Node SUVmax values were divided by the
SUVmax of the primary tumour, descending aorta and
liver to calculate the following:
 nodal SUVmax/primary tumour SUVmax
 nodal SUVmax/aortic SUVmax
 nodal SUVmax/liver SUVmax
The short and long axis of the largest node in each
nodal basin were also recorded.
Only cervical nodal levels 1 to 5 were examined in this
study as these were the most common levels removed in
a neck dissection.
Two nuclear medicine physicians then systematically
examined each PET/CT scan visually and determined
which cervical nodal levels had metastatic nodes. This
was compared to the pathology results. A nodal basin
with at least one metastatic node was deemed to be a
‘metastatic basin’, regardless of the number of metastatic
nodes within the basin or the size of the metastatic
deposit(s).
Histopathological analysis
Neck dissection specimens were either removed level by
level or enbloc and then divided into the individual
nodal levels. Nodal evaluation was performed by dedi-
cated head and neck pathologists at our institution, in
accordance with the guidelines issued by the Royal
College of Pathologists in the United Kingdom. The
specimens were inspected and palpated and each
discrete palpable node was dissected out with attached
peri-capsular adipose tissue. These nodes were then
placed in a cassette which was then stained and serially
sliced prior to being loaded onto pathology slides for
viewing under the microscope. Pathologic findings on
the lymph nodes were recorded at each anatomic level.
Only lymph nodes in cervical levels one to five were
examined–intra-parotid, occipital or pre-auricular nodes
were excluded.
The pathology reports were reviewed by the investiga-
tors to determine if the nodal basin contained any
metastatic nodes.
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Statistical analysis
All statistical analyses were performed using IBM SPSS
version 22 by two bio-statisticians. The pathologic status
and SUVmax of cervical lymph nodes were collected for
calculating the receiver operating characteristic (ROC)
curve and Youden’s Index for determining the cut-off
value for SUVmax. The Youden index, which is a com-
prehensive measurement for the performance of a diag-
nostic test, was generated considering every possible
cut-off point. The value that generates the highest You-
den’s Index for the particular ratio is considered as the
best cut-off for that ratio, as it provides highest discrim-
ination between pathology and no pathology. A p-value
of 0.05 or less was considered statistically significant.
Binary logistic regression was applied to assess the
association of individual predictor with chance of metas-
tasis adjusting for all possible confounding. For choosing
the most suitable predictor for metastatic node a back-
ward logistic regression was fitted including all plausible
predictors. P <0.05 was considered as significant.
Results
Patient demographics
The study cohort consisted of 74 patients with HNSCC,
including 57 males and 17 females. The median patient
age was 64 (range 35–89). Primary sites included the
oral cavity, hypopharynx, larynx and skin. Five patients
had no primary site found (Table 1).
Type of neck dissection
A total of 95 neck-sides, including 359 nodal basins,
were dissected (Table 2). Metastatic nodes were found in
86 of 359 levels (24.0 %). The most common neck
dissection performed was a selective neck dissection of
levels I to IV (33.7 %) followed by a selective neck
dissection of levels II to IV (21.1 %), supra-omohyoid
neck dissection of levels I to III (SOHND) (17.9 %)
modified radical neck dissection of levels I to V (MRND)
(13.7 %), selective neck dissection of levels II to V
(8.4 %) and radical neck dissection of levels I to V
(5.3 %).
SUVmax for pathologically positive and negative lymph
nodes and the cut-off value for diagnosis
SUVmax was measured for the largest lymph node in
each level and compared with the results of histopathologic
examination. The median SUVmax values of pathologically
negative and positive nodes were 1.55 (range 0.58–5.2) and
5 (range 0.91–23.49) respectively. The median primary
tumour SUVmax was 14.26 (range 3.89–36.69). The median
aortic SUVmax was 2.70 (range 1.79–4.68). The median liver
SUVmax was 3.38 (range 2.27–5.51).
A Receiver Operating Characteristic (ROC) curve was
drawn and the Youden’s Index used to determine the
cut-off value for SUVmax at which sensitivity and specifi-
city were the highest (Table 3). The best nodal SUVmax
cut-off was found to be 3.16. This yielded a sensitivity of
74.4 % and specificity of 84.9 %.
SUVmax ratios for pathologically positive and negative
lymph nodes and the cut-off value for diagnosis
A ROC analysis was employed to evaluate usefulness of
three different ratios in determining the presence or
absence of metastatic nodes:
 nodal SUVmax/primary tumour SUVmax
 nodal SUVmax/aortic SUVmax
 nodal SUVmax/liver SUVmax
The results are shown in Fig. 1 and Table 4.
ROC analysis of Nodal SUVmax/Primary SUVmax ratio,
Nodal SUVmax/Aorta SUVmax ratio and Nodal SUVmax/
Liver SUVmax ratio confirms that the latter two ratios
are good predictors of nodal metastasis (Fig. 1). Nodal
SUVmax/Primary SUVmax ratio was a poorer predictor
than the other two ratios. To choose the best predictor
Table 1 Primary Sites
Primary site Frequency Percent













% of tumours ipsilateral
to the positive node
% of tumours contralateral
to the positive node
% of tumours midline
to the positive node
% of positive nodes with
unknown primaries
Level I 70 18 10/18 (55.6 %) 1/18 (5.6 %) 3/18 (16.7 %) 4/18 (22.2 %)
Level II 95 33 18/33 (54.5 %) 3/33 (9.1 %) 5/33 (15.1 %) 7/33 (21.2 %)
Level III 95 21 12/21 (57.1 %) 1/21 (4.8 %) 6/21 (28.6 %) 2/21 (9.5 %)
Level IV 77 10 6/10 (60.0 %) 0/10 (0 %) 3/10 (30.0 %) 1/10 (10.0 %)
Level V 27 4 2/4 (50.0 %) 0/4 (0 %) 2/4 (50.0 %) 0/4 (0 %)
Total 364 86 48/86 (55.8 %) 5/86 (5.8 %) 19/86 (22.1 %) 14/86 (16.3 %)
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of nodal metastasis adjusting for all possible confound-
ing factors a stepwise backward elimination multi-
variable logistic regression analysis was performed on all
the potential PET predictors of nodal metastasis. After
each step, the predictor with the lowest p-value was
removed. By the end of the analysis, nodal SUVmax/liver
SUVmax ratio was found to be the best predictor for
nodal metastasis (Table 4).
The optimal cut-off value for nodal SUVmax/liver
SUVmax ratio is 0.903. This means that a node with a
nodal SUVmax/liver SUVmax of greater than or equal to
0.903 is considered metastatic with a sensitivity of
74.1 % and specificity of 93.4 % (Table 5).
Comparing visual detection of metastatic nodes, nodal
SUVmax and nodal SUVmax/liver SUVmax
ROC analysis of visual detection of metastatic nodes,
nodal SUVmax and nodal SUVmax/liver SUVmax ratio
found that while visual detection demonstrated good
discrimination between metastatic and benign nodes, the
use of nodal SUVmax and nodal SUVmaz/liver SUVmax had
better discrimination. The area under the curves for visual
observer 1 was 0.737 and 0.703 for visual observer 2. In
contrast, the area under the curve was 0.883 for both
nodal SUVmax and nodal SUVmaz/liver SUVmax (Table 6
and Fig. 2). Observer 1 detected metastatic nodes with a
sensitivity of 66.3 % and a specificity of 77.7 %, while the
corresponding values for Observer 2 were 61.6 and
86.5 %. Using a Nodal SUVmax/Liver SUVmax ratio of
>0.903 yielded a sensitivity of 72.8 % and specificity
of 93.8 %.
Short and long nodal diameters had no statistically
significant impact on predicting nodal basin metastasis
The short and long axis of the largest node in each nodal
basin were recorded. Neither diameter was a statistically
significant predictor of a metastatic basin (Table 7).
Multi-variable analysis of various indicators of metastatic
nodes
Multivariable logistic regression was conducted with
plausible indicators of metastatic nodes. Adjusting for all
possible confounders and indicators entered in the
model nodal SUVmax appeared as significant indicator
of metastatic nodes. (OR 3.275; 95%CI: 2.018–5.317;
P < 0.000). None of the other factors ‘primary tumour
SUVmax’ (p > 0.05), ‘extra-capsular spread’ (p > 0.05),
‘nodal necrosis’ (p > 0.05), largest nodal diameter (p > 0.05)
and smallest nodal diameter (p > 0.05) appeared to be
significant indicators of metastatic nodes (Table 8).
Table 3 ROC analysis for generating nodal SUVmax Cut-off with maximum sensitivity and specificity
Highest Youden’s Index Cut-offa Sensitivity Specificity Likelihood Ratio Pos. Test Likelihood Ratio Neg. Test
Nodal SUVmax 0.693 3.16 0.744 0.849 14.57 0.270
aPositive if greater Than or Equal To
Fig. 1 ROC curves of Nodal SUVmax/Primary SUVmax Ratio, Nodal SUVmax/Aortic SUVmax Ratio and Nodal SUVmax/Liver SUVmax Ratio
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Discussion
The introduction of 18 F-FDG PET/CT has greatly
improved preoperative staging of HNSCC. As the pres-
ence of nodal metastasis is one of the most important
prognostic factors for patients with HNSCC, accurate
nodal staging of these patients is essential for both
appropriate management and prognostic purposes
[2, 7, 10].
For malignancies with a high risk of occult nodal
metastasis, such as oral cavity SCC, elective neck dissec-
tions are routinely performed on patients with clinically
negative necks. This serves staging as well as therapeutic
purposes. However, for patients in whom an elective dis-
section is not planned based on the site and histological
grade of the primary tumour, nodal staging is based
solely on clinical examination and radiological imaging.
In these cases, the use of SUVmax can aid in distinguish-
ing between metastatic and benign nodes, and thus in
deciding whether an elective neck dissection should be
undertaken.
The standardized uptake value (SUV) is the most
widely used method for the quantification of 18 F-FDG
uptake [11]. The SUV of a target can be expressed as
SUVmean or SUVmax. SUVmean is the average SUV calcu-
lated from multiple voxels, while SUVmax is the highest
voxel SUV reading in the region of interest. [12] The
SUVmax is the more common method of reporting SUV,
due to the fact that it is more reproducible and less
observer-dependent than SUVmean [12, 13]. The SUVmax
is used at our institution for this reason. In our study,
we have also decided to perform a per-nodal-level
analysis as this analysis is commonly presented in the lit-
erature and allows comparison with other studies.
The use of SUVmax to detect nodal metastases has
been studied extensively in lung cancers, but not in head
and neck malignancies. A study by Bryant et al. included
397 patients with non-small cell lung cancer and found
that the median SUVmax of metastatic mediastinal lymph
nodes was significantly higher than that of benign nodes.
Indeed, when a SUVmax cutoff of 5.3 was used instead of
the traditional value of 2.5, the accuracy of 18 F-FDG-
PET/CT for detecting mediastinal lymph node metasta-
sis increased to 92 % [14]. Another study by Ela Bella
et al. looked at the ideal SUVmax cutoff for identification
of metastatic mediastinal lymph nodes and found SUVmax
of 4.1 to be ideal. This cut-off yielded a sensitivity of 80 %
and specificity of 92 % [15]. A similar SUVmax cut-off for
identifying metastatic mediastinal lymph nodes was
reported by Vansteenkiste et al. [16].
The use of SUVmax to detect nodal metastases in the
head and neck has only been reported in two studies. In
2012, Matsubara et al. looked at 38 patients with oral
SCC and compared their pre-operative 18 F-FDG-PET/CT
scan results with histopathological findings [8]. The
authors reported that nodes with a SUVmax of more than
4.5 were all pathologically confirmed as being metastatic,
but for nodes with SUVmax ≤ 4.5, it was not possible to
distinguish between true positives and false positives.
Hence, the long and short axis diameters were measured
for those nodes and the long-axis diameter was found to
be significantly longer in the true positive nodes. No
significant difference between the true positive and false
positive nodes were found in the short-axis diameter.
Murakami et al. studied 23 patients with HNSCC and
found that SUVmax accurately characterized lymph
nodes >15 mm in diameter, but was not reliable with
respect to nodes <15 mm. Thus, size based SUVmax cut-
offs were used in this study: they were 1.9 for nodes less
than 10 mm in diameter, 2.5 for those 10–15 mm, and
3.0 for nodes more than 15 mm. These values yielded
79 % sensitivity and 99 % specificity [9].
The limitations of these studies are the small sample
sizes and the lack of accounting for other variables that
could influence SUV readings. These include the blood
sugar level of the patient at the time of PET scanning,
the presence of an inflammatory process near the
tumour, patient movement and the interval between
injection of 18 F-FDG and acquisition of PET.
In our study, we have found that nodal SUVmax was
a statistically significant predictor of metastatic nodes
(p < 0.001), and that a nodal SUVmax cut-off of ≥3.16
yielded a sensitivity of 74.4 % and specificity of 84.9 %. We
Table 4 Stepwise multi-variable logistic regression analysis
Predictor B S.E. P Value OR 95 % C.I. for OR
Lower Upper
Nodal SUVmax/Liver SUVmax 4.114 0.556 .000* 61.1 20.2 185.6
Constant −4.642 0.496 .000 0.010
*Statistically significant
Table 5 Optimal nodal SUVmax/liver SUVmax ratio for generating Cut-off with maximum sensitivity and specificity
Highest Youden’s Index Cut-offa Sensitivity Specificity Likelihood Ratio Pos. Test Likelihood Ratio Neg. Test
Nodal SUVmax/Liver SUVmax ratio 0.675 0.903 0.741 0.934 11.266 0.277
aPositive if greater Than or Equal To
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then hypothesized that a ratio of SUVmax values (ie, nodal
SUVmax/background SUVmax) may be one way to negate
these inherent differences between PET centres and
standardize the measurement. Thus we measured the
SUVmax of the liver parenchyma, aortic blood pool and
primary tumour to see if these ratios could improve the
detection of metastatic nodes. Multi-variable logistic
regression analysis found the nodal SUVmax/liver SUVmax
ratio to be able to distinguish, with statistical significance,
between metastatic and benign nodes. This ratio offered a
similar sensitivity as nodal SUVmax alone (74.1 % com-
pared to 74.4 %). The significance of our results are that
the nodal SUVmax/liver SUVmax is able to negate inherent
differences between patients and PET centres and there-
fore standardize the measurement.
This is the first study to propose using a SUV ratio to
detect metastatic cervical nodes. Currently, the lack of
literature on this matter means that arbitrary SUVmax
cut-off values are used. These vary significantly between
institutions and the evidence for their use is lacking.
Using the nodal SUVmax cut-off and/or the SUVmaz ratio
cut-off proposed in this study, in addition to the usual
methods of detecting a nodal metastasis, might improve
the overall sensitivity and specificity of PET/CT for the
detection of metastatic nodes.
Improving the pre-operative detection of nodal metas-
tasis is important as it has the potential to alter surgical
management. In patients for whom an elective dissection
is not planned based on the site and histological grade
of the primary tumour, nodal staging is based mainly on
clinical examination and radiological imaging. In these
cases, the use of nodal SUVmax alone or nodal SUVmax/
liver SUVmax can aid in distinguishing between meta-
static and benign nodes, and thus in deciding whether
an elective neck dissection should be undertaken.
Using a nodal SUVmax/liver SUVmax ratio also allows
comparison of nodal tracer uptake between PET scans
performed using different scanners. Currently, a com-
parison is not meaningful due to differences in scanner
calibration and thus SUV readings. However, a ratio
would negate inherent differences between scanners,
making it possible to compare a pre-treatment PET scan
with a post-treatment PET scan performed at a different
centre to assess treatment response.
While we think the use of nodal SUVmax/liver SUVmax
ratio is promising, there are a few caveats in the use of
Table 6 Receiver operating characteristics of visual detection and nodal SUVmax/liver SUVmax ratio
Sensitivity Specificity PPV NPV AUC (95 % CI)
Observer 1 61.63 86.45 58.89 87.73 0.703 (0.633, 0.772)
Observer 2 66.28 77.66 48.31 87.97 0.737 (0.667, 0.807)
N/L SUV (≥0.903) 72.84 93.78 81.94 89.91 0.883 (0.772, 0.894)
Fig. 2 ROC curves of visual detection, and nodal SUVmax/liver SUVmax ratio
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liver SUV as a proxy for background SUVmax. The first
is that the liver has an abundance of glucose-6-
phosphatase, which could cause continuous glycolysis
and reduce its measured SUV more rapidly compared to
other tissues. However, a prospective study by Laffon et
al. performed PET acquisition at two time points on the
same day and reported that the decay-corrected SUV of
the liver remains nearly constant if the time delay be-
tween tracer injection and PET acquisition is in the
range of 50–110 min. [17] This suggests that in clinical
practice, liver SUV can be used for comparison with
SUV of suspected malignant lesions, if comparison is
made within this timeframe.
Another caveat of using liver SUV is in the presence
of fatty liver. This has been suggested to result in a
slightly decreased metabolic activity [18], while another
study reported no significant difference in SUVmax [19].
The presence of liver tumours or metastatic disease
would also give spurious liver SUV readings [20].
The main drawback of using nodal SUVmax is that this
measurement might be spuriously low in necrotic nodes.
In these cases, correlation with CT findings is essential.
Another limitation of this study is the time lapse be-
tween the PET/CT scan and surgery. The median time
between a patient in our study having the PET/CT scan
and the neck dissection was 27 days (range 1–62). Disease
progression could have occurred during this time and
what was initially a benign node at the time of scanning
could have turned malignant by the time of surgery.
Despite these limitations, our study has shown nodal
SUVmax and nodal SUVmax/liver SUVmax ratio to be
better detectors of metastatic nodes than visual inspec-
tion. This is surprising as visual interpretation integrates
more information than the nodal SUVmax or SUVmax ra-
tio measurements, in particular the distribution pattern,
size, number and relative intensity of lesions and the
relationship of the lesions with the primary tumour, to
determine the probability of these foci of uptake repre-
senting metastatic disease. A meta-analysis by Sun et al.
published in 2015 included 19 studies that performed a
per-nodal-level analysis and found that the pooled sensi-
tivity and specificity was 80 % (range 0 %–96.3 %) and
96 % (range 73.4 %–98.9 %) respectively [21]. We
acknowledge that our sensitivities and specificities for
visual inspection were somewhat lower than this but
when a Nodal SUVmax/Liver SUVmax ratio of >0.903 was
used the sensitivity and specificity yielded was comparable.
A few reasons may account for the difference. Firstly,
selective reporting bias may have contributed to the high
reported sensitivities and specificities of 18FDG-PET/CT
in the meta-analysis. Furthermore, 12 of the 19 studies
that were included in the meta-analysis had either CT
and/or MRI performed in addition to the 18FDG-PET/
CT. Thus, it is possible that the imaging observers might
have known the diagnostic outcome of other conventional
imaging methods before assessing the results of 18FDG-
PET/CT imaging, resulting in a spuriously high sensitivity
and specificity for 18FDG-PET/CT.
Conclusions
This preliminary study has identified two predictors of
metastatic nodes on PET scans–nodal SUVmax and nodal
SUVmax/liver SUVmax ratio. It is the first study examin-
ing the utility of a SUV ratio in detection of metastatic
cervical lymph nodes and more data are needed from a
larger number of patients from multiple centres. Further
research could examine prospectively if these predictors,
combined with conventional visual detection methods,
are able to improve the overall accuracy of detecting
metastatic cervical lymph nodes.
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